Securities Fraud Investigation Into Soleno Therapeutics, Inc. (SLNO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Core Viewpoint - Glancy Prongay Wolke & Rotter LLP has initiated an investigation into Soleno Therapeutics, Inc. regarding potential violations of federal securities laws affecting investors [1] Company Summary - The investigation is on behalf of investors who may have incurred losses related to Soleno Therapeutics, Inc. (NASDAQ: SLNO) [1]